2019
DOI: 10.1097/coh.0000000000000564
|View full text |Cite
|
Sign up to set email alerts
|

The HIV epidemic in Latin America

Abstract: Purpose of review To describe how countries in Latin America and the Caribbean are (or are not) meeting 2016 WHO guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, that is, their progress on the adoption of ‘Treat All’ and of preexposure prophylaxis (PrEP) as an additional prevention tool for people at substantial risk of HIV infection. Recent findings The HIV epidemic in the region continues largely concentrated in vulnerable popul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
24
1
2

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 65 publications
(36 citation statements)
references
References 53 publications
0
24
1
2
Order By: Relevance
“…Even after a health system restructuring in 2008 that guaranteed more access to ART [ 8 ], Colombia still ranks low on various indices among all LA countries in terms of overall ARV coverage, HIV testing and PLWHA population proportion with suppressed viral load. In addition, by the end of 2018, Colombia still had not adopted the Pre-Exposure Prophylaxis (PrEP) to HIV [ 6 , 22 ]. Countries that adopted the Universal Treatment and Test for HIV policy (UTT) have observed an increasing number of PLWHA with suppressed viral load and decreasing HIV incidence and AIDS-related deaths [ 23 , 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…Even after a health system restructuring in 2008 that guaranteed more access to ART [ 8 ], Colombia still ranks low on various indices among all LA countries in terms of overall ARV coverage, HIV testing and PLWHA population proportion with suppressed viral load. In addition, by the end of 2018, Colombia still had not adopted the Pre-Exposure Prophylaxis (PrEP) to HIV [ 6 , 22 ]. Countries that adopted the Universal Treatment and Test for HIV policy (UTT) have observed an increasing number of PLWHA with suppressed viral load and decreasing HIV incidence and AIDS-related deaths [ 23 , 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…These trends may also reflect prevalent gender norms [ 49 ], unequal access to timely diagnosis and treatment [ 48 ], or differences in disease burden from comorbidities between genders [ 1 ]. The spatial distribution of high-risk groups possibly also contributes to the HIV epidemic remaining concentrated in large urban centres [ 6 ]. For example, one important driver of spatial differences in HIV mortality is prison populations, where HIV transmission is high due to overcrowding, violence, and lack of information on the risk of HIV acquisition [ 53 ].…”
Section: Discussionmentioning
confidence: 99%
“…Notably, our analysis in Ecuador only extends to 2014 and patterns of HIV mortality may have changed with the recent emphasis on community testing and treatment in metropolitan areas [ 63 ]. While all countries have expanded access to treatment and documented increases in ART coverage, albeit at different time periods, persistent disparities in access to quality health services and adherence to ART remain [ 6 , 64 , 65 ] and may contribute to differences in HIV mortality declines observed in this analysis. Further, in all countries in our analysis, communities with socioeconomic and health disadvantages—such as indigenous communities, sex workers, and transgender populations—often have unequal access to treatment and are an emerging or establish public health priority [ 66 , 67 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations